The graft touchdown: what changes in the first 72 hours? the 2026 ISHLT consensus, a necessary redefinition
A new ISHLT consensus document addresses graft dysfunction within the first 72 hours after transplantation.
Heart failure and circulatory devices
Malrotation of the Impella in cardiogenic shock: a frequent and probably underrecognized complication with a hemorrhagic toll
Retrospective observational study assessing the incidence of Impella malrotation in patients with cardiogenic shock and its potential association with clinical complications and early prognosis.
Driveline thinner and more flexible: the possible key to achieving the lowest possible infection risk?
A retrospective, multicentre study from 9 centres in China evaluating 181 patients treated with a novel durable ventricular assist device featuring a fully magnetically levitated centrifugal pump and an ultrathin, highly flexible driveline designed to reduce local trauma at the exit site and, consequently, infection.
When donation after circulatory death changes the heart transplant waiting list
Observational cohort study analysing the impact of implementing a heart transplantation programme based on controlled donation after circulatory death on clinical outcomes from the time of inclusion on the waiting list.
Xenotransplantation in cardiac surgery: current status and future perspectives
This article provides an excellent overview of the historical development of cardiac xenotransplantation (transplantation using organs from other species) and clearly outlines the key concepts required to understand the current state of this technique.
Management of post-infarction ventricular septal defect: is early microaxial support the new turning point?
This single-center retrospective observational study evaluates the impact of an initial strategy based on microaxial flow support with Impella® devices, comparing percutaneous models (Impella 2.5®/CP®) with high-flow devices surgically implanted via the axillary approach (Impella 5.0®/5.5®), and their effect on clinical stabilization, access to delayed surgery, and early survival in patients with post-infarction ventricular septal defect (VSD).
Pediatric Cardiac Donation After Circulatory Death: When Technical Progress Forces Us to Redefine Death
Contemporary review of the different modalities of pediatric cardiac donation after circulatory death
Spanish heart transplant registry 2025: consolidation of activity and new horizons in donation after circulatory death
The Spanish Heart Transplant Registry presents the results of the activity corresponding to 2024, analyzing trends in recipient and donor profiles, the use of mechanical circulatory support, and survival patterns over the past decade.
Surgical treatment of tricuspid regurgitation: a new ally in patients with long-term ventricular assist devices?
A randomized US trial aimed to determine whether concomitant tricuspid valve surgery (TVS) at the time of durable left ventricular assist device (LVAD) implantation reduces tricuspid regurgitation (TR) and the incidence of long-term right heart failure (RHF).
Ventricular support in children with congenital heart disease: time to join “ACTION” promptly!
This study analyzes data from the ACTION registry to assess whether morbidity and mortality after ventricular assist device (VAD) implantation differ between children with and without congenital heart disease (CHD), and whether outcomes among those with CHD vary according to anatomy (single- vs. biventricular).